Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 25, 2022

Carvedilol Reduces Decompensation and Mortality Risk in Patients With Compensated Cirrhosis and Portal Hypertension

Journal of Hepatology


Additional Info

Journal of Hepatology
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
J. Hepatol. 2022 Oct 01;77(4)1014-1025, C Villanueva, F Torres, SK Sarin, HA Shah, D Tripathi, A Brujats, SG Rodrigues, A Bhardwaj, Z Azam, PC Hayes, A Jindal, S Abid, E Alvarado, J Bosch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading